about
sameAs
Mitochondrial function in vascular endothelial cell in diabetesOrally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemia-reperfusion.High awareness of diabetes in the health care system in Greenland measured as a proportion of population tested with glycated haemoglobin within 2 yearsOxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.Cilostazol minimizes venous ischemic injury in diabetic and normal rats.Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats.Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).Hyperglycemia aggravates decreases of PEA-15 and its two phosphorylated forms in cerebral ischemia.The role of the blood transcriptome in innate inflammation and stroke.Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease--an overview.Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.Oxidative stress and platelet activation: markers of myocardial infarction in type 2 diabetes mellitus.Platelet aggregation is not enhanced in patients with prediabetes.Potentiation of aspirin-induced cerebroprotection by minocycline: a therapeutic approach to attenuate exacerbation of transient focal cerebral ischaemia.Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.
P2860
Q28383025-1E21A091-D2FC-4F69-BDDB-68B3DB0233CEQ33570445-4A78373F-BF28-4865-B928-0B61158AB852Q33634906-417CC00E-F755-4095-BFCF-2EB8B29DCA83Q33659216-9B095F6C-893F-48A5-8BC2-A68EE9AD1BBFQ33877253-12139FF4-46EC-4B4F-B60E-16CA1B135C44Q36343103-F243FD47-7125-4232-B676-2658D9E72316Q37412202-A4DC92AF-08F6-4D57-852A-FBF289239B36Q37740116-0C4AC667-1650-4761-A6D9-C808768E5AA6Q37800988-01CF6ECD-45E5-4818-8838-A00F25708CEEQ37991017-73F5BB9E-AC28-4FAF-8507-5269D4828C80Q38620860-B99A55A7-FD12-4C14-8D77-AF3624F7A506Q40149784-4111FD01-9EC5-43AC-B011-BEEE4B377507Q42455401-D24BBD39-2FC6-4BA9-A39C-A73D52212AB6Q43275703-56E49ABB-2CF2-4879-9349-E6290F5EB80DQ43724690-9FA79AF6-9841-4354-8B26-245FCD2F7379Q45905073-581B80AC-8A5A-482D-806A-791B6621B2D8Q50056816-E4601C48-7C0D-49DC-A030-D0FBFDAABA8A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականին հրատարակուած գիտական յօդուած
@hyw
2002 թվականին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Diabetes and macrovascular disease
@ast
Diabetes and macrovascular disease
@en
Diabetes and macrovascular disease
@nl
type
label
Diabetes and macrovascular disease
@ast
Diabetes and macrovascular disease
@en
Diabetes and macrovascular disease
@nl
prefLabel
Diabetes and macrovascular disease
@ast
Diabetes and macrovascular disease
@en
Diabetes and macrovascular disease
@nl
P1476
Diabetes and macrovascular disease
@en
P2093
Aaron Vinik
Mark Flemmer
P304
P356
10.1016/S1056-8727(01)00212-4
P407
P577
2002-01-01T00:00:00Z